Glenmark Pays USD 25 Million to Settle US Pricing Case
September 5, 2024 10:57
Glenmark Pharmaceuticals has agreed to pay USD 25 million to settle a US Department of Justice investigation into pricing practices related to a generic drug. The settlement includes restitution...